The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Subscribe To Our Newsletter & Stay Updated
